Mechanisms and pathophysiologic significance of insulin's vascular action

Current Opinion in Endocrinology and Diabetes

Volumn 5, Issue 3, 1998, Pages 217-222

  Cleland, Stephen J ^a   Petrie, John R ^a   Ueda, Shinichiro ^a   Elliott, Henry L ^a   Connell, John M C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASODILATOR AGENT;

GLUCOSE METABOLISM; HEART FAILURE; HUMAN; HUMAN CELL; HYPERTENSION; INSULIN RESISTANCE; OBESITY; PATHOPHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0031832969     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199806000-00012     Document Type: Review

References (69)

1. De Fronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992, 15:316-368.
2. Yki-Jarvinen H, Koivisto VA: Effect of body composition on insulin sensitivity. Diabetes 1983, 32:965-969.
3. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357.
4. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF: Insulin resistance in chronic heart failure. Eur Heart J 1994, 15:1528-1532.
5. Williams SB, Cusco JA, Roddy M, Johnstone MT, Creager MA: Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996, 27:567-574.
6. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 1996, 97:2601-2610.
7. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993, 87:1468-1474.
8. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R: Endothelial function in chronic heart failure. Am J Cardiol 1993, 126:761-764.
9. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994, 94:2511-2515.
10. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994, 94:1172-1179.
11. De Fronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
12. Natali A, Buzzigoli G, Taddi S, Sanatoro D, Cerri M, Pedrinelli R, Ferrannini E: Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes 1990, 39:490-500.
13. Yki-Jarvinen H, Young AA, Lamkin C, Foley JE: Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 1987, 79:1713-1719.
14. Laakso M, Edelman SV, Brechtel G, Baron AD: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992, 41:1076-1083.
15. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991, 87:2246-2252.
16. Neahring JM, Stepniakowski K, Greene AS, Egan BM: Insulin does not reduce forearm α-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension 1993, 22:584-590.
17. Baron AD: Cardiovascular actions of insulin in humans: implications for insulin sensitivity and vascular tone. Baillieres Clin Endocrinol Metab 1993, 7:961-987.
18. Natali A, Taddei S, Galvan AQ, Camastra S, Baldi S, Frascerra S, Virdis A, Sudano I, Salvetti A, Ferrannini E: Insulin sensitivity, vascular reactivity and clamp-induced vasodilatation in essential hypertension. Circulation 1997, 96:849-855.
19. Utriainen T, Nuutila P, Takala T, Vicini P, Ruotsalainen U, Ronnemaa T, Tolvanen T, Raitakari M, Haaparanta M, Kirvela O, et al.: Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest 1997, 100:777-785.
20. Baron A: Hemodynamic actions of insulin. Am J Physiol 1994, 267:E187-E202.
21. Tack CJ, Lutterman JA, Vervoort G, Thien T, Smits P: Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension 1996, 28:426-432.
22. Raitakari M, Nuutila P, Ruotsalainen U, Laine H, Teras M, Iida H, Makimattila S, Utriainen T, Oikonen V, Sipila H, et al.: Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle. Diabetes 1996, 45:1471-1477.
23. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U: Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994, 93:2365-2371.
24. Ueda S, Petric JR, Cleland SJ, Elliott HL, Connell JMC: The vasodilatory effect of insulin is dependent on local glucose uptake - a double-blind, placebo-controlled study. J Clin Endocrinol Metab, in press.
25. Lembo G, Iaccarino G, Vecchioe C, Rendina V, Parrella L, Trimarco B: Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. Circulation 1996, 93:1403-1410.
26. Sakai K, Imaizumi T, Masaki H, Takeshita A: Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension 1993, 22:67-73.
27. Lembo G, Iaccarino G, Rendina V, Volpe M, Trimarco B: Insulin blunts sympathetic vasoconstriction through the α2-adrenergic pathway in humans. Hypertension 1994, 24:429-438.
28. 2-and β-adrenergic responses in human forearm. J Clin Invest 1997, 100:2007-2014.
29. Randin D, Vollenweider P, Tappy L, Jequier E, Nicod P, Scherrer U: Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol 1994, 266:RB09-R816.
30. + pump activity by insulin and nitric oxide in rabbit aorta. Am J Physiol 1996, 270:H1287-H1293.
31. +-ATPase in rat arterial smooth muscle. Am J Physiol 1997, 273:E113-E121.
32. Sowers JR: Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism. Diabetes 1996, 45(suppl 3):S47-S51.
33. - excretion. Metabolism 1997, 46:406-409.
34. Utriainen T, Makimattila S, Virkamaki A, Lindholm H, Sovijarvi A, Yki-Jarvinen H: Physical fitness and endothellal function (nitric oxide synthesis) are independent determinants of insulin-simulated blood flow in man. J Clin Endocrinol Metab 1996, 81:4258-4263.
35. Van Veen S, Chang PC: Prostaglandins and nitric oxide mediate insulin-induced vasodilation in the human forearm. Cardiovasc Res 1997, 34:223-229.
36. Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JMC: Insulin vasodilatation is abolished by both L-NMMA and angiotensin II [abstract]. Hypertension 1997, 15(suppl 4):S71.
37. Wu H-Y, Young YJ, Yue C-J, Kuang-Yuh C, Hsueh WA, Chan TM: Endothelial-dependent vascular effects of insulin and insulin-like growth factor-1 in the perfused rat mesenteric artery and aortic ring. Diabetes 1994, 43:1027-1032.
38. Chen Y-L, Messina EJ: Dilation of isolated skeletal muscle arterioles by insulin is endothelium dependent and nitric oxide mediated. Am J Physiol 1996, 270:H2120-H2124.
39. McKay MK, Hester RL: Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulin-induced vasodilation. Hypertension 1996, 28:202-208.
40. Ueda S, Petrie JR, Cleland SJ, Elliott HL, Connell JMC: Insulin vasodilatation and the "arginine paradox." Lancet 1998, 351:959-960.
41. +) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J Physiol 1996, 490:775-781.
42. 2+ level and contraction in the rat aorta: endothelium-dependent and -independent mechanisms. Circ Res 1995, 77:673-678.
43. Luckhoff A, Busse R: Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Schmiedebergs Arch Pharmacol 1990, 342:94-99.
44. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A: Effect of insulin on acetylcholine-induced vasodilation in normal subjects and in patients with essential hypertension. Circulation 1995, 92:2911-2918.
45. McNally PG, Lawrence IG, Watt PAC, Hillier C, Burden AC, Thurston H: The effect of insulin on the vascular reactivity of isolated resistance arteries taken from healthy volunteers. Diabetologia 1995, 38:467-473.
46. Polderman KH, Stehouwer CDA, van Kamp GJ, Gooren LJG: Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia 1996, 39:1284-1292.
47. Clark MG, Colquhoun EQ, Rattigan S, Dora KA, Eldershaw TPD, Hall JL, Ye J: Vascular and endocrine control of muscle metabolism. Am J Physiol 1995, 268:E797-E812.
48. Graier WF, Wascher TC, Lackener L, Tplak H, Krejs GJ, Kukovetz WR: Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes 1993, 42:1497-1505.
49. 2+ influx and contraction in vascular smooth muscle. Circulation 1995, 92:1597-1603.
50. Baron AD, Steinberg HO: Endothelial function, insulin sensitivity and hypertension. Circulation 1997, 96:725-726.
51. Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G: Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 1995, 96:786-792.
52. Feldman RD, Hramiak IM, Finegood DT, Behme MT: Parallel regulation of the local vascular and systemic metabolic effects of insulin. J Clin Endocrinol Metab 1995, 80:1556-1559.
53. Petrie J, Ueda S, Webb DJ, Elliott HL, Connell JMC: Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996, 93:1331-1333.
54. Utriainen TR, Makimattila S, Virkamaki A, Bergholm R, Yki-Jarvinen H: Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia 1996, 39:1477-1482.
55. Wu G, Majumdar S, Zhang J, Lee H, Meinenger CJ: Insulin stimulates glycolysis and pentose cycle activity in bovine microvascular endothelial cells. Comp Biochem Physiol A Physiol 1994, 108A:179-185.
56. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin. J Clin Invest 1996, 98:894-898.
57. Pinkney JH, Stehouwer CDA, Coppack SW, Yudkin JS: Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997, 46(suppl 2):S9-S13.
58. Natali A, Bonadonna R, Santoro D, Galvan AQ, Baldi S, Frascerra S, Palombo C, Ghione S, Ferrannini E: Insulin resistance and vasodilation in essential hypertension: studies with adenosine. J Clin Invest 1994, 94:1570-1576.
59. Yki-Jarvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 1995, 38:1378-1388.
60. 18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest 1996, 97:1741-1747.
61. Hunter SJ, Harper R, Ennis CN, Sheridan B, Atkinson AB, Bell PM: Skeletal muscle blood flow is not a determinant of insulin resistance in essential hypertension. J Hypertens 1997, 15:73-77.
62. Wascher TC, Graier WF, Dittrich P, Hussain MA, Bahadori B, Wallner S, Toplak H: Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Invest 1997, 27:690-695.
63. Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L, Cozzolino D, D'Onofrio F: The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest 1997, 99:433-438.
64. Stehouwer CDA, Lambert J, Donker AJM, van Hinsbergh VWM: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997, 34:55-68.
65. Reaven GM, Chen Yl, Jeppesen J, Maheux P, Krauss RM: Insulin resistance and hyperinsulinaemia in individuals with small density low density lipoprotein particles. J Clin Invest 1993, 92:141-146.
66. DiCorleto PE, Soyombo AA: The role of the endothelium in atherogenesis. Curr Opin Lipidol 1993, 4:364-372.
67. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM: Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 1995, 26:764-770.
68. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997, 100:1230-1239. This study was designed as a follow-up to the demonstration that obesity and dyslipidemia might exert an important confounding influence on endothelial function in metabolic disease (J Clin Invest 1996, 97:2601-2610). In healthy individuals, free fatty acids were infused in the presence of somatostatin (to inhibit systemic insulin release) and endothelial dysfunction ensued. When insulin levels were restored, endothelial function was normalized. These results suggest that circulating free fatty acids may play an important role in blunting endothelial function.
69. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997, 100:1230-1239. This study was designed as a follow-up to the demonstration that obesity and dyslipidemia might exert an important confounding influence on endothelial function in metabolic disease (J Clin Invest 1996, 97:2601-2610). In healthy individuals, free fatty acids were infused in the presence of somatostatin (to inhibit systemic insulin release) and endothelial dysfunction ensued. When insulin levels were restored, endothelial function was normalized. These results suggest that circulating free fatty acids may play an important role in blunting endothelial function.